Author:
Miyazaki Tatsuhiko,Nakata Hiroshi,Kato Keiichi
Reference58 articles.
1. Wu PK, Chen WM, Chen CF, Lee OK, Haung CK, Chen TH. Primary osteogenic sarcoma with pulmonary metastasis: Clinical results and prognostic factors in 91 patients. Japanese Journal of Clinical Oncology. 2009;39(8):514–522. DOI: 10.1093/jjco/hyp057
2. Clark JC, Dass CR, Choong PF. A review of clinical and molecular prognostic factors in osteosarcoma. Journal of Cancer Research and Clinical Oncology. 2008;134(3):281–297. DOI: 10.1007/s00432-007-0330-x
3. Kimura H, Tsuchiya H, Shirai T, Nishida H, Hayashi K, Takeuchi A, Ohnari I, Tomita K. Caffeine-potentiated chemotherapy for metastatic osteosarcoma. Journal of Orthopaedic Science. 2009;14(5):556–565. DOI: 10.1007/s00776-009-1372-5
4. Tsuchiya H, Tomita K, Mori Y, Asada N, Morinaga T, Kitano S, Yamamoto N. Caffeine-assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma. Anticancer Research. 1998;18(1B):657–666
5. Hayashi K, Tsuchiya H, Yamamoto N, Shirai T, Yamauchi K, Takeuchi A, Kawahara M, Miyamoto K, Tomita K. Impact of serum caffeine monitoring on adverse effects and chemotherapeutic responses to caffeine-potentiated chemotherapy for osteosarcoma. Journal of Orthopaedic Science. 2009;14(3):253–258. DOI: 10.1007/s00776-009-1336-9